-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
![Evaluation plasma nucloesomes dogs Wilson Robles BMC featured image](https://volition.com/wp-content/uploads/2024/01/Evaluation-plasma-nucloesomes-dogs-Wilson-Robles-BMC-featured-image.jpg)
Evaluation of plasma nucleosome concentrations in dogs
- Share
- Tweet
- Share on Facebook
- Share
![Evaluation plasma nucloesomes dogs Wilson Robles BMC thumbnail](https://volition.com/wp-content/uploads/2024/01/Evaluation-plasma-nucloesomes-dogs-Wilson-Robles-BMC-thumbnail.jpg)
![Evaluation plasma nucloesomes dogs Wilson Robles BMC thumbnail](https://volition.com/wp-content/uploads/2024/01/Evaluation-plasma-nucloesomes-dogs-Wilson-Robles-BMC-thumbnail.jpg)
Paper titled: ‘Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers.’
Published in BMC Veterinary Research 2022
Dr Heather Wilson-Robles et al
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields